RxDoctor Payments Data

Rene'e Shepherd, DPM

Foot & Ankle Surgery · Supply, NCNPI 1558713420

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (56.5%), education and travel and lodging — rather than concentrated in one kind of arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 22.3%. Reporting peaked in 2022 at $2,317 and has fallen 51.5% since, to $1,124 in 2025.

$8,788in general payments, 2019–2025

Across 90 payments — averaging $97.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$2K
  • Fortis Surgical, LLC$1K
  • Micromed Inc$1K
  • Amgen$633
  • Paratek Pharmaceuticals, Inc.$423
  • Smith+Nephew$376
  • plus $3K from 21 others

What the payments were for

  • Travel & lodging$1,42416%
  • Food & beverage$4,96356%
  • Education$2,40027%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,788 in reported general payments places this provider in the 75th percentile of 196 foot & ankle surgery providers in North Carolina.

See all foot & ankle surgery providers in North Carolina

Medicare billing

Part B allowed, 2024
$119,660
Medicare patients
594
Services billed
1,985

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox30$842
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip16$323
Mupirocin34$287
Methylprednisolone48$258
Diclofenac Sodium12$229
Terbinafine Hcl23$221
Silver Sulfadiazine25$160
Ammonium Lactate11$152
Cephalexin17$133
Pregabalin16$89
Doxycycline Hyclate12$67
Meloxicam16$18

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Supply

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →